Literature DB >> 22240596

Hemodialysis-induced P-wave signal-averaged electrocardiogram alterations are indicative of vulnerability to atrial arrhythmias.

Kentaro Shimada1, Takeshi Tomita, Yuji Kamijo, Makoto Higuchi, Kenichi Ito, Yoichi Koizumi, Kazuya Yamamoto, Kazunori Aizawa, Megumi Koshikawa, Hiroki Kasai, Atsushi Izawa, Yusuke Miyashita, Setsuo Kumazaki, Jun Koyama, Uichi Ikeda.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common supraventricular arrhythmia, often occurring during hemodialysis (HD). Prolongation of the total filtered P-wave duration (PWD) and reduction of the root mean square voltages for the last 20 ms of the P wave (RMS20) on a P-wave signal-averaged electrocardiogram (P-SAECG) are predictors of AF. We investigated whether HD induces alterations of P-SAECG, and determined the influential factors. METHODS AND
RESULTS: Thirty-three end-stage kidney disease patients (66.7 ± 12.6 years, 23 males) undergoing maintenance HD were enrolled in this study. Digital ambulatory P-SAECG monitoring and laboratory examination of serum proteins and ions were carried out before, during, and after the HD sessions. Data were analyzed by multiple regression analysis. PWD was significantly prolonged, and RMS20 significantly reduced, during HD. These values recovered after completion of HD. Multiple regression analysis showed that prolongation of PWD significantly correlated with HD duration and the rate of removal of body fluid. On the other hand, RMS20 significantly correlated with HD duration and blood urea nitrogen variation.
CONCLUSIONS: HD resulted in prolongation of PWD and reduction of RMS20, indicating the vulnerability of HD patients to AF. These P-SAECG changes correlated with HD duration and the rate of removal of the body fluid. These findings underline the importance of the control of dialysis variables in the prevention of atrial arrhythmias following HD.

Entities:  

Mesh:

Year:  2012        PMID: 22240596     DOI: 10.1253/circj.cj-11-1000

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Relationship between electrical conduction and phasic left atrial function: P-wave signal-averaged electrocardiography and time-left atrial volume curve assessments using two-dimensional speckle-tracking echocardiography.

Authors:  Shinichiro Tanaka; Toshiyuki Noda; Masanori Kawasaki; Tomonori Segawa; Natsumi Tsugita; Takahiro Fuseya; Tomoki Kubota; Makoto Iwama; Kazuhiko Nishigaki; Sachiro Watanabe; Taro Minagawa; Hiroshige Ohashi; Shinya Minatoguchi
Journal:  Heart Vessels       Date:  2019-01-25       Impact factor: 2.037

2.  Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogram.

Authors:  Alida Páll; Árpád Czifra; Veronika Sebestyén; Gergely Becs; Csaba Kun; József Balla; György Paragh; István Lőrincz; Dénes Páll; Tamás János Padra; Anupam Agarwal; Abolfazl Zarjou; Zoltán Szabó
Journal:  Int Urol Nephrol       Date:  2015-11-11       Impact factor: 2.370

3.  Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study.

Authors:  David M Charytan; Robert Foley; Peter A McCullough; John D Rogers; Peter Zimetbaum; Charles A Herzog; James A Tumlin
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-13       Impact factor: 8.237

4.  A Systematic Review of the Incidence of Arrhythmias in Hemodialysis Patients Undergoing Long-Term Monitoring With Implantable Loop Recorders.

Authors:  Paul R Roberts; Kurt Stromberg; Lawrence C Johnson; Benedict M Wiles; Thomas A Mavrakanas; David M Charytan
Journal:  Kidney Int Rep       Date:  2020-11-02

5.  Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis.

Authors:  Bruce A Koplan; Wolfgang C Winkelmayer; Alexandru I Costea; Prabir Roy-Chaudhury; James A Tumlin; Vijay Kher; Don E Williamson; Saurabh Pokhariyal; David M Charytan
Journal:  Kidney Int Rep       Date:  2021-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.